What are the MRCP findings of pancreas divisum?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

MRCP Findings of Pancreas Divisum

MRCP is particularly helpful in identifying pancreas divisum by demonstrating the failure of fusion between the dorsal and ventral pancreatic ductal systems, with the key finding being a dominant dorsal pancreatic duct that crosses the lower bile duct and drains independently through the minor papilla without communicating with the ventral duct. 1

Primary Diagnostic Features on MRCP

The classic MRCP findings that establish the diagnosis of pancreas divisum include:

  • Non-communicating dorsal and ventral ducts - The hallmark finding showing complete lack of fusion between the two ductal systems 2, 3

  • Dominant dorsal pancreatic duct - This duct drains the majority of the pancreatic parenchyma and crosses anterior to the common bile duct 2, 3

  • Independent drainage sites - The dorsal duct empties through the minor papilla while the small ventral duct (when visible) drains through the major papilla 2, 4

  • Absent or diminutive ventral duct - In complete pancreas divisum, the ventral duct may be absent or appear as only a short segment in the pancreatic head region 4

Additional MRCP Findings

Santorinicele - A small cystic dilatation of the dorsal duct at the minor papilla can be identified, particularly when present, and may indicate outflow obstruction 2, 5. This finding is detected in approximately 21-50% of patients with pancreas divisum, with detection rates significantly improved by secretin-enhanced MRCP 5.

Role of Secretin-Enhanced MRCP

While standard MRCP is effective, secretin-enhanced MRCP improves diagnostic yield by:

  • Increasing detection of pancreas divisum by approximately 23% compared to standard MRCP 6
  • Better visualizing the dorsal duct anatomy through physiologic distension 6, 5
  • Identifying santorinicele in additional cases not seen on standard imaging 5

However, the 2022 AGA guidelines note that secretin-enhanced MRCP has limited clinical utility due to availability constraints, logistics of secretin administration, and variability in acquisition and interpretation 1.

Diagnostic Performance

Standard MRCP demonstrates:

  • Sensitivity: 63-81% for detecting pancreas divisum 7
  • Specificity: 91-97% 7
  • Positive predictive value: 91-94% 7

Important caveat: Pancreas divisum may remain uncharacterized in 19-37% of patients on preprocedural MRI, particularly when the pancreatic duct is dilated or in cases of incomplete divisum 7. Diagnostic accuracy improves with normal duct diameter and complete divisum anatomy 7.

Clinical Context

Pancreas divisum occurs in approximately 6-10% of the population and represents the most common congenital pancreatic anomaly 1. MRCP is particularly valuable for identifying this anatomical variant as a potential cause of unexplained acute or recurrent pancreatitis, though the majority of patients with pancreas divisum remain asymptomatic 1.

The 2022 AGA guidelines position MRI/MRCP as a reasonable complementary or alternative test to EUS for evaluating unexplained pancreatitis, with MRCP being especially useful for identifying pancreatic ductal etiologies and anatomical variants like pancreas divisum 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.